Researchers have uncovered how certain genetic mutations lead to unique spherical amyloid plaques in inherited forms of ...
Researchers have identified the structure of amyloid beta fibrils linked to a rare inherited form of Alzheimer’s disease ...
Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering novel, genetically validated therapies for ...
This manuscript provides fundamental studies to help us better understand the effects of mutations in the presenilin-1 (PSEN1) gene on proteolytic processing of the amyloid precursor protein (APP).
Alector’s AbbVie-partnered Alzheimer's disease asset has failed to slow disease progression in a phase 2 study, the latest in ...
Why Alzheimer's disease strikes some people but not others is still largely mysterious. But in about one percent of cases ...
An international collaboration led by RIKEN researchers has discovered how unusual spherical structures form in the brains of ...
New research from Auburn University shows a new drug might be a preventive for Alzheimer’s Disease. The study’s main ...
Neuroinflammation can be caused by a range of factors, including stress, and can lead to irreversible consequences like ...
Neuroinflammation can cause a range of health issues, many of which may be irreversible if left untreated for too long ...
"Alector stock drops after Alzheimer’s drug fails in Phase II trial" was originally created and published by Clinical Trials ...
Scientists studied 188 people related to someone with ALS caused by a C9ORF72 mutation to identify markers of disease risk in ...